CN Stock MarketDetailed Quotes

300760 Shenzhen Mindray Bio-Medical Electronics

Watchlist
  • 225.27
  • -4.59-2.00%
Market Closed Apr 3 15:00 CST
273.13BMarket Cap22.05P/E (TTM)

Shenzhen Mindray Bio-Medical Electronics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
7.99%29.48B
11.12%20.53B
12.06%9.37B
15.04%34.93B
17.20%27.3B
20.32%18.48B
20.47%8.36B
20.17%30.37B
20.13%23.3B
20.17%15.36B
Operating revenue
7.99%29.48B
11.12%20.53B
12.06%9.37B
15.04%34.93B
17.20%27.3B
20.32%18.48B
20.47%8.36B
20.17%30.37B
20.13%23.3B
20.17%15.36B
Other operating revenue
----
79.38%39.29M
----
378.66%56.61M
----
319.44%21.91M
----
0.82%11.83M
----
25.02%5.22M
Total operating cost
7.97%17.87B
8.20%12.39B
8.99%6.07B
10.92%21.99B
14.62%16.55B
19.74%11.45B
20.36%5.57B
18.95%19.83B
19.16%14.44B
19.24%9.56B
Operating cost
5.84%10.36B
9.00%6.93B
13.50%3.19B
8.59%11.82B
17.68%9.79B
15.40%6.36B
16.00%2.81B
23.10%10.89B
24.69%8.32B
25.20%5.51B
Operating tax surcharges
9.30%314.82M
19.99%222.22M
19.06%100.81M
5.11%366.08M
13.51%288.04M
17.27%185.21M
6.57%84.67M
23.51%348.29M
17.80%253.77M
15.20%157.93M
Operating expense
6.10%3.66B
3.54%2.93B
8.13%1.49B
18.77%5.7B
3.71%3.45B
31.72%2.83B
28.04%1.37B
20.07%4.8B
17.12%3.33B
14.77%2.15B
Administration expense
0.32%1.12B
3.38%822.53M
3.56%473.35M
15.43%1.52B
19.86%1.12B
28.58%795.64M
27.54%457.08M
19.39%1.32B
10.35%930.89M
4.82%618.81M
Financial expense
69.86%-182.37M
48.78%-292.75M
-2,005.68%-123.74M
-89.54%-854.91M
-25.56%-604.99M
-156.10%-571.56M
23.49%-5.88M
-424.62%-451.04M
-460.38%-481.83M
-418.38%-223.18M
-Interest expense (Financial expense)
61.00%14.2M
64.67%9.13M
71.67%4.47M
21.62%13M
15.71%8.82M
15.19%5.55M
15.15%2.6M
23.77%10.69M
21.74%7.62M
15.30%4.81M
-Interest Income (Financial expense)
17.50%-434.21M
-8.26%-316.36M
-37.07%-189.76M
-129.57%-821.64M
-107.87%-526.34M
-67.48%-292.21M
-56.25%-138.44M
12.13%-357.91M
19.44%-253.21M
21.92%-174.47M
Research and development
3.32%2.59B
-4.11%1.78B
11.16%947.43M
17.45%3.43B
20.19%2.51B
37.13%1.85B
21.07%852.3M
15.78%2.92B
28.11%2.09B
27.19%1.35B
Credit Impairment Loss
-211.51%-188.2M
-136.21%-134.33M
-40.35%-66.41M
-563.32%-244.19M
-489.62%-60.42M
-749.41%-56.87M
-840.64%-47.32M
-733.20%-36.81M
63.95%-10.25M
71.79%-6.7M
Asset Impairment Loss
-34.13%-161.03M
-18.59%-91.14M
-2.10%-43.45M
-644.80%-529.51M
-148.73%-120.05M
-169.50%-76.85M
-107.55%-42.56M
46.03%-71.09M
27.33%-48.27M
22.07%-28.52M
Other net revenue
7.34%477.8M
44.01%440.26M
152.53%272.94M
-71.40%129.16M
23.55%445.12M
43.27%305.72M
22.19%108.08M
-2.60%451.63M
12.77%360.29M
29.79%213.39M
Fair value change income
108.56%126.88M
280.65%126.28M
--126.03M
471.42%79.4M
384.58%60.84M
255.19%33.18M
----
-316.40%-21.38M
-381.92%-21.38M
-216.68%-21.38M
Invest income
1,397.18%64.22M
3,628.47%63.44M
-183.94%-3.1M
-94.43%-9.84M
-24.47%-4.95M
30.20%-1.8M
6.92%-1.09M
-723.73%-5.06M
-90.34%-3.98M
-68.55%-2.58M
-Including: Investment income associates
-183.20%-14.23M
-815.04%-14.11M
-183.94%-3.1M
-108.97%-9.82M
-26.32%-5.02M
40.12%-1.54M
6.92%-1.09M
-678.93%-4.7M
-90.34%-3.98M
-68.55%-2.58M
Asset deal income
83.62%7.93M
3,216.14%3.54M
46.80%-316.18K
-60.02%2.46M
-28.90%4.32M
-114.86%-113.62K
91.08%-594.32K
51.61%6.16M
113.10%6.08M
-51.77%764.43K
Other revenue
11.08%628M
15.75%472.47M
30.33%260.19M
43.29%830.84M
29.06%565.38M
50.18%408.18M
75.13%199.64M
0.87%579.82M
4.80%438.08M
17.44%271.79M
Operating profit
7.99%12.1B
17.06%8.58B
23.20%3.57B
18.92%13.07B
21.49%11.2B
22.06%7.33B
20.74%2.9B
21.23%10.99B
21.38%9.22B
22.00%6.01B
Add:Non operating Income
-18.40%29.48M
-14.38%15.56M
-17.63%7.47M
59.70%56.35M
29.23%36.13M
13.48%18.18M
77.50%9.07M
51.81%35.28M
66.84%27.96M
40.66%16.02M
Less:Non operating expense
48.95%74.23M
41.34%54.21M
4.16%22.04M
59.56%115.28M
165.45%49.84M
193.69%38.35M
2,146.26%21.16M
0.52%72.25M
-34.17%18.77M
-25.63%13.06M
Total profit
7.72%12.05B
16.85%8.54B
23.21%3.56B
18.78%13.01B
21.23%11.19B
21.66%7.31B
20.03%2.89B
21.48%10.95B
21.69%9.23B
22.21%6.01B
Less:Income tax cost
-0.26%1.35B
11.43%965.61M
25.59%395.92M
6.68%1.43B
20.40%1.35B
20.70%866.58M
5.53%315.26M
32.56%1.34B
22.26%1.12B
25.78%717.94M
Net profit
8.82%10.7B
17.58%7.58B
22.92%3.16B
20.47%11.58B
21.34%9.84B
21.79%6.44B
22.09%2.57B
20.07%9.61B
21.61%8.11B
21.74%5.29B
Net profit from continuing operation
8.82%10.7B
17.58%7.58B
22.92%3.16B
20.47%11.58B
21.34%9.84B
21.79%6.44B
22.09%2.57B
20.07%9.61B
21.61%8.11B
21.74%5.29B
Less:Minority Profit
5,267.36%65.57M
1,144.20%15.2M
54.87%1.89M
-207.62%-3.81M
-64.60%1.22M
-53.59%1.22M
-35.72%1.22M
42.15%3.54M
41.22%3.45M
145.75%2.63M
Net profit of parent company owners
8.16%10.64B
17.37%7.56B
22.90%3.16B
20.56%11.58B
21.38%9.83B
21.83%6.44B
22.14%2.57B
20.07%9.61B
21.60%8.1B
21.71%5.29B
Earning per share
Basic earning per share
8.12%8.7808
17.41%6.2446
22.80%2.6107
20.38%9.5586
21.30%8.1216
21.76%5.3187
22.36%2.126
20.55%7.9402
22.14%6.6955
22.24%4.3682
Diluted earning per share
8.12%8.7776
17.41%6.2413
22.80%2.6091
20.42%9.5577
21.25%8.1185
21.69%5.3157
22.28%2.1247
20.50%7.9369
22.14%6.6955
22.24%4.3682
Other composite income
-134.90%-69.48M
-141.99%-135.27M
-2,363.48%-116.26M
-9.26%272.83M
59.46%199.12M
925.22%322.17M
106.30%5.14M
204.70%300.67M
224.24%124.87M
212.38%31.42M
Other composite income of parent company owners
-136.70%-73.08M
-141.30%-133.06M
-2,240.44%-109.94M
-9.65%271.65M
59.46%199.12M
925.22%322.17M
106.30%5.14M
204.70%300.67M
224.24%124.87M
212.38%31.42M
Other composite income of minority owners
--3.59M
---2.22M
---6.32M
--1.19M
----
----
----
----
----
----
Total composite income
5.96%10.63B
9.98%7.44B
18.16%3.05B
19.57%11.85B
21.92%10.03B
27.13%6.77B
27.25%2.58B
28.44%9.91B
25.38%8.23B
23.26%5.32B
Total composite income of parent company owners
5.29%10.56B
9.81%7.43B
18.39%3.05B
19.64%11.85B
21.95%10.03B
27.17%6.76B
27.31%2.58B
28.43%9.91B
25.37%8.23B
23.23%5.32B
Total composite income of minority owners
5,561.52%69.17M
962.61%12.98M
-462.44%-4.43M
-174.16%-2.63M
-64.60%1.22M
-53.59%1.22M
-35.72%1.22M
42.15%3.54M
41.22%3.45M
145.75%2.63M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 7.99%29.48B11.12%20.53B12.06%9.37B15.04%34.93B17.20%27.3B20.32%18.48B20.47%8.36B20.17%30.37B20.13%23.3B20.17%15.36B
Operating revenue 7.99%29.48B11.12%20.53B12.06%9.37B15.04%34.93B17.20%27.3B20.32%18.48B20.47%8.36B20.17%30.37B20.13%23.3B20.17%15.36B
Other operating revenue ----79.38%39.29M----378.66%56.61M----319.44%21.91M----0.82%11.83M----25.02%5.22M
Total operating cost 7.97%17.87B8.20%12.39B8.99%6.07B10.92%21.99B14.62%16.55B19.74%11.45B20.36%5.57B18.95%19.83B19.16%14.44B19.24%9.56B
Operating cost 5.84%10.36B9.00%6.93B13.50%3.19B8.59%11.82B17.68%9.79B15.40%6.36B16.00%2.81B23.10%10.89B24.69%8.32B25.20%5.51B
Operating tax surcharges 9.30%314.82M19.99%222.22M19.06%100.81M5.11%366.08M13.51%288.04M17.27%185.21M6.57%84.67M23.51%348.29M17.80%253.77M15.20%157.93M
Operating expense 6.10%3.66B3.54%2.93B8.13%1.49B18.77%5.7B3.71%3.45B31.72%2.83B28.04%1.37B20.07%4.8B17.12%3.33B14.77%2.15B
Administration expense 0.32%1.12B3.38%822.53M3.56%473.35M15.43%1.52B19.86%1.12B28.58%795.64M27.54%457.08M19.39%1.32B10.35%930.89M4.82%618.81M
Financial expense 69.86%-182.37M48.78%-292.75M-2,005.68%-123.74M-89.54%-854.91M-25.56%-604.99M-156.10%-571.56M23.49%-5.88M-424.62%-451.04M-460.38%-481.83M-418.38%-223.18M
-Interest expense (Financial expense) 61.00%14.2M64.67%9.13M71.67%4.47M21.62%13M15.71%8.82M15.19%5.55M15.15%2.6M23.77%10.69M21.74%7.62M15.30%4.81M
-Interest Income (Financial expense) 17.50%-434.21M-8.26%-316.36M-37.07%-189.76M-129.57%-821.64M-107.87%-526.34M-67.48%-292.21M-56.25%-138.44M12.13%-357.91M19.44%-253.21M21.92%-174.47M
Research and development 3.32%2.59B-4.11%1.78B11.16%947.43M17.45%3.43B20.19%2.51B37.13%1.85B21.07%852.3M15.78%2.92B28.11%2.09B27.19%1.35B
Credit Impairment Loss -211.51%-188.2M-136.21%-134.33M-40.35%-66.41M-563.32%-244.19M-489.62%-60.42M-749.41%-56.87M-840.64%-47.32M-733.20%-36.81M63.95%-10.25M71.79%-6.7M
Asset Impairment Loss -34.13%-161.03M-18.59%-91.14M-2.10%-43.45M-644.80%-529.51M-148.73%-120.05M-169.50%-76.85M-107.55%-42.56M46.03%-71.09M27.33%-48.27M22.07%-28.52M
Other net revenue 7.34%477.8M44.01%440.26M152.53%272.94M-71.40%129.16M23.55%445.12M43.27%305.72M22.19%108.08M-2.60%451.63M12.77%360.29M29.79%213.39M
Fair value change income 108.56%126.88M280.65%126.28M--126.03M471.42%79.4M384.58%60.84M255.19%33.18M-----316.40%-21.38M-381.92%-21.38M-216.68%-21.38M
Invest income 1,397.18%64.22M3,628.47%63.44M-183.94%-3.1M-94.43%-9.84M-24.47%-4.95M30.20%-1.8M6.92%-1.09M-723.73%-5.06M-90.34%-3.98M-68.55%-2.58M
-Including: Investment income associates -183.20%-14.23M-815.04%-14.11M-183.94%-3.1M-108.97%-9.82M-26.32%-5.02M40.12%-1.54M6.92%-1.09M-678.93%-4.7M-90.34%-3.98M-68.55%-2.58M
Asset deal income 83.62%7.93M3,216.14%3.54M46.80%-316.18K-60.02%2.46M-28.90%4.32M-114.86%-113.62K91.08%-594.32K51.61%6.16M113.10%6.08M-51.77%764.43K
Other revenue 11.08%628M15.75%472.47M30.33%260.19M43.29%830.84M29.06%565.38M50.18%408.18M75.13%199.64M0.87%579.82M4.80%438.08M17.44%271.79M
Operating profit 7.99%12.1B17.06%8.58B23.20%3.57B18.92%13.07B21.49%11.2B22.06%7.33B20.74%2.9B21.23%10.99B21.38%9.22B22.00%6.01B
Add:Non operating Income -18.40%29.48M-14.38%15.56M-17.63%7.47M59.70%56.35M29.23%36.13M13.48%18.18M77.50%9.07M51.81%35.28M66.84%27.96M40.66%16.02M
Less:Non operating expense 48.95%74.23M41.34%54.21M4.16%22.04M59.56%115.28M165.45%49.84M193.69%38.35M2,146.26%21.16M0.52%72.25M-34.17%18.77M-25.63%13.06M
Total profit 7.72%12.05B16.85%8.54B23.21%3.56B18.78%13.01B21.23%11.19B21.66%7.31B20.03%2.89B21.48%10.95B21.69%9.23B22.21%6.01B
Less:Income tax cost -0.26%1.35B11.43%965.61M25.59%395.92M6.68%1.43B20.40%1.35B20.70%866.58M5.53%315.26M32.56%1.34B22.26%1.12B25.78%717.94M
Net profit 8.82%10.7B17.58%7.58B22.92%3.16B20.47%11.58B21.34%9.84B21.79%6.44B22.09%2.57B20.07%9.61B21.61%8.11B21.74%5.29B
Net profit from continuing operation 8.82%10.7B17.58%7.58B22.92%3.16B20.47%11.58B21.34%9.84B21.79%6.44B22.09%2.57B20.07%9.61B21.61%8.11B21.74%5.29B
Less:Minority Profit 5,267.36%65.57M1,144.20%15.2M54.87%1.89M-207.62%-3.81M-64.60%1.22M-53.59%1.22M-35.72%1.22M42.15%3.54M41.22%3.45M145.75%2.63M
Net profit of parent company owners 8.16%10.64B17.37%7.56B22.90%3.16B20.56%11.58B21.38%9.83B21.83%6.44B22.14%2.57B20.07%9.61B21.60%8.1B21.71%5.29B
Earning per share
Basic earning per share 8.12%8.780817.41%6.244622.80%2.610720.38%9.558621.30%8.121621.76%5.318722.36%2.12620.55%7.940222.14%6.695522.24%4.3682
Diluted earning per share 8.12%8.777617.41%6.241322.80%2.609120.42%9.557721.25%8.118521.69%5.315722.28%2.124720.50%7.936922.14%6.695522.24%4.3682
Other composite income -134.90%-69.48M-141.99%-135.27M-2,363.48%-116.26M-9.26%272.83M59.46%199.12M925.22%322.17M106.30%5.14M204.70%300.67M224.24%124.87M212.38%31.42M
Other composite income of parent company owners -136.70%-73.08M-141.30%-133.06M-2,240.44%-109.94M-9.65%271.65M59.46%199.12M925.22%322.17M106.30%5.14M204.70%300.67M224.24%124.87M212.38%31.42M
Other composite income of minority owners --3.59M---2.22M---6.32M--1.19M------------------------
Total composite income 5.96%10.63B9.98%7.44B18.16%3.05B19.57%11.85B21.92%10.03B27.13%6.77B27.25%2.58B28.44%9.91B25.38%8.23B23.26%5.32B
Total composite income of parent company owners 5.29%10.56B9.81%7.43B18.39%3.05B19.64%11.85B21.95%10.03B27.17%6.76B27.31%2.58B28.43%9.91B25.37%8.23B23.23%5.32B
Total composite income of minority owners 5,561.52%69.17M962.61%12.98M-462.44%-4.43M-174.16%-2.63M-64.60%1.22M-53.59%1.22M-35.72%1.22M42.15%3.54M41.22%3.45M145.75%2.63M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
WINSUNBIO
839729
+29.98%
HIGO
872351
+29.93%
DRIVE
838275
+20.30%
4
Shanghai Menon Animal Nutrition Technology
301156
+20.03%
5
Nanjing Railway New Technology
301016
+20.02%
Log In for the Full List
Unlock Now